Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
The DOI matches its Crossref record; 23 of the 26 references it cites were found in a registry or an index.
Abstract
We analyzed data from the National Nosocomial Infections Surveillance (NNIS) System from 1986-2003 to determine the epidemiology of gram-negative bacilli in intensive care units (ICUs) for the most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI). We analyzed >410,000 bacterial isolates associated with hospital-acquired infections in ICUs during 1986-2003. In 2003, gram-negative bacilli were associated with 23.8% of BSIs, 65.2% of pneumonia episodes, 33.8% of SSIs, and 71.1% of UTIs. The percentage of BSIs associated with gram-negative bacilli decreased from 33.2% in 1986 to 23.8% in 2003. The percentage of SSIs associated with gram-negative bacilli decreased from 56.5% in 1986 to 33.8% in 2003. The percentages pneumonia episodes and UTIs associated with gram-negative bacilli remained constant during the study period. The proportion of ICU pneumonia episodes associated with Acinetobacter species increased from 4% in 1986 to 7.0% in 2003 (P<.001, by the Cochran-Armitage chi2 test for trend). Significant increases in resistance rates were uniformly seen for selected antimicrobial-pathogen combinations. Gram-negative bacilli are commonly associated with hospital-acquired infections in ICUs. The proportion of Acinetobacter species associated with ICU pneumonia increased from 4% in 1986 to 7.0% in 2003.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a group, these organisms are the most common etiology of nosocomial infections, including most cases of hospital-acquired pneumonia, ventilator-associated pneumonia and healthcare-associated pneumonia, and they are important causes of morbidity and death in hospitalized patients (1).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [1]
Citations
Cites
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Self-citationSurveillance nosokomialer Infektionen
Gastmeier (2004) · Therapeutische Umschau · doi:10.1024/0040-5930.61.3.204 · Cited by 509
Epidemiology and control of nosocomial infections in adult intensive care units
Weinstein, R. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90366-6 · Cited by 300 · cited 1×
“the 4 most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI) [1].”
BackgroundSelf-citationMultidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285 · cited 1×
“Acinetobacter organisms are intrinsically resistant to many antimicrobials and can acquire resistance to others [7].”
BackgroundHOSPITAL ACQUIRED INFECTIONS: KNOWLEDGE ABOUT IT AND ITS PREVENTION
QAYYUM, S., WAQAS, B., & SATTAR, A. (2010) · The Professional Medical Journal · doi:10.29309/tpmj/2010.17.02.2211 · Cited by 256
MAGNITUDE AND PREVENTION OF NOSOCOMIAL INFECTIONS IN THE INTENSIVE CARE UNIT
Fridkin, S. K., Welbel, S. F., & Weinstein, R. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70366-4 · Cited by 225 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
BackgroundSelf-citationStreit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Syncope and orthostatic hypotension
Atkins, D., Hanusa, B., Sefcik, T., & Kapoor, W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90012-m · Cited by 172
Research works printed but not linked: 2
- 1991, The American journal of medicine, 91, 86
- Richards, 2003, Annals of surgery, 237, 358, 10.1097/00000658-200303000-00009 · doi:10.1097/00000658-200303000-00009
Cited by
Items 501–600 of 1,000
Becker, E., Husain, M., Bone, N. B., Smith, S., Morris, P. E., & Zmijewski, J. W. (2023) · Respiratory Research · doi:10.1186/s12931-023-02483-6 · Cited by 33
Kooti, S., Motamedifar, M., & Sarvari, J. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.20215v2 · Cited by 32
Respiratory Infections Due to Drug-Resistant Bacteria
Song, J., & Chung, D. R. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.04.007 · Cited by 34
Williams, J. D., Nguyen, S. T., Gu, S., Ding, X., Butler, M. M., Tashjian, T. F., Opperman, T. J., Panchal, R. G., Bavari, S., Peet, N. P., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.014 · Cited by 32
An Individual-Based Model of Transmission of Resistant Bacteria in a Veterinary Teaching Hospital
Suthar, N., Roy, S., Call, D. R., Besser, T. E., & Davis, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098589 · Cited by 32
Huang, C., Long, Q., Qian, K., Fu, T., Zhang, Z., Liao, P., & Xie, J. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.09.015 · Cited by 32
“multiple antibiotics [1–3].”
4‐Quinolone Derivatives and Their Activities Against Gram‐negative Pathogens
Jiang, D. (2018) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.3244 · Cited by 32
Krinko (2007) · Robert-Koch-Institut (RKI) · doi:10.25646/157 · Cited by 33
Kidd, J. M., Kuti, J. L., & Nicolau, D. P. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1438408 · Cited by 32
Koshak, A. E., Okairy, H. M., Elfaky, M. A., Abdallah, H. M., Mohamed, G. A., Ibrahim, S. R. M., Alzain, A. A., Abulfaraj, M. W., Hegazy, W. A. H., & Nazeih, S. I. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117611 · Cited by 31
Zhao, L., KuoLee, R., Harris, G., Tram, K., Yan, H., & Chen, W. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.03.024 · Cited by 31
Acinetobacter baumannii and endocarditis, rare complication but important clinical relevance
Laganà, P., Melcarne, L., & Delia, S. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.019 · Cited by 31
Liu, X., Shao, K., & Sun, T. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000343352 · Cited by 31
Draghi, D. C., Tench, S., Dowzicky, M. J., & Sahm, D. F. (2008) · Chemotherapy · doi:10.1159/000118660 · Cited by 31
“Antimicrobial resistance continues to present challenges for the treatment of infections caused by organisms acquired in the community and the hospital [ , , , , ,”
BackgroundMüsken, M., Pawar, V., Schwebs, T., Bähre, H., Felgner, S., Weiß, S., & Häußler, S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01635-18 · Cited by 34
“This opportunistic pathogen has emerged as one of the most important pathogens involved in acute nosocomial infections (7).”
BackgroundIncreasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999–2006
Hoffmann, M. S., Eber, M. R., & Laxminarayan, R. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/650379 · Cited by 30
Sobel, J. D., & Kaye, D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00069-2 · Cited by 30
Aydemir, H., Çelebi, G., Pişkin, N., Öztoprak, N., Keskin, A. S., Aktaş, E., Sümbüloğlu, V., & Akduman, D. (2012) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.65.66 · Cited by 30
Blood stream Infections in chronic hemodialysis patients - characteristics and outcomes
Pravda, M. S., Maor, ., Brodsky, K., Katkov, A., Cernes, R., Pravda, N. S., Tocut, M., Zohar, I., Soroksky, A., & Feldman, L. (2024) · BMC Nephrology · doi:10.1186/s12882-023-03442-5 · Cited by 30
“There is an increasing body of evidence demonstrating worldwide changes in the pattern of pathogens causing BSI in HD patients [19–21].”
BackgroundNica, I. C., Stan, M. S., Dinischiotu, A., Popa, M., Chifiriuc, M. C., Lazăr, V., Pîrcălăbioru, G. G., Bezirtzoglou, E., Iordache, O. G., Varzaru, E., et al. (2016) · Nanomaterials · doi:10.3390/nano6110214 · Cited by 30
Garg, M., Johri, S., Sagar, S., Mundhada, A., Agrawal, A., Ray, P., & Chakraborty, K. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108736 · Cited by 30
Šiširak, M., & Hukić, M. (2013) · Acta Medica Academica · doi:10.5644/ama2006-124.67 · Cited by 29
Bush, L. M., Chaparro-Rojas, Okeh, & Étienne (2011) · Infection and Drug Resistance · doi:10.2147/idr.s15610 · Cited by 29
Management of antibiotic resistance in the intensive care unit setting
Petrosillo, N., Capone, A., Bella, S. D., & Taglietti, F. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.7 · Cited by 29
Cefepime-Resistant Pseudomonas aeruginosa
Akhabue, E., Synnestvedt, M. B., Weiner, M. G., Bilker, W. B., & Lautenbach, E. (2011) · Emerging infectious diseases · doi:10.3201/eid/1706.100358 · Cited by 32
Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections
Wenzler, E., Goff, D. A., Humphries, R. M., & Goldstein, E. J. C. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0149-y · Cited by 32
Silva, N., de Oliveira, M. M., Bandeira, A. C., & Brites, C. R. (2006) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702006000300007 · Cited by 29
Chen, H., Au, K., Hsu, E. K., Lai, C. K. C., Myint, J., Mak, Y., Lee, S. Y., Wong, T., & Tsang, N. (2018) · Hong Kong Medical Journal · doi:10.12809/hkmj176949 · Cited by 28
Wei, X., Li, L., Li, M., Liang, H., He, Y., & Li, S. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s396428 · Cited by 28
An, Y., Fang, X., Cheng, J., Yang, S., Chen, Z., & Tong, Y. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00581j · Cited by 28
Kazamori, D., Aoi, H., Sugimoto, K., Ueshima, T., Amano, H., Itoh, K., Kuramoto, Y., & Yazaki, A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.017 · Cited by 28
Dejardin, D., Delmar, P., Warne, C. D., Patel, K., van Rosmalen, J., & Lesaffre, E. M. E. H. (2017) · Pharmaceutical Statistics · doi:10.1002/pst.1843 · Cited by 30
Tharmalingam, N., Rajmuthiah, R., Kim, W., Fuchs, B. B., Jeyamani, E., Kelso, M. J., & Mylonakis, E. E. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0250 · Cited by 29
de Mello, M. M., de Barros, P. P., Bernardes, R. D. C., Alves, S. R., Ramanzini, N. P., Figueiredo-Godoi, L. M. A., Prado, A. C. C., Jorge, A. O. C., & Junqueira, J. C. (2019) · Lasers in Medical Science · doi:10.1007/s10103-019-02773-w · Cited by 28
“Gaynes and Edwards [17] analyzed 400,000 nosocomial isolates registered at the National Nosocomial Infections Surveillance (NNIS) in Atlanta (USA) from 1986 to 2003 and found 7% of A. baumannii isolates, a rate slightly higher than that observed in the present study.”
BackgroundInfluentialDella‐Latta, P., Salimnia, H., Painter, T., Wu, F., Procop, G. W., Wilson, D. A., Gillespie, W., Mender, A., & Crystal, B. S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02250-10 · Cited by 27
Djordjevic, Z. M., Јаnkovic, S., Gajović, O., Djonović, N., Folic, N. D., & Bukumirić, Z. (2012) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.2659 · Cited by 27
Monogue, M. L., Kuti, J. L., & Nicolau, D. P. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1133286 · Cited by 27
“representation in numerous nosocomial-acquired infections[1].”
Innate Immune Responses to Acinetobacter baumannii in the Airway
Pires, S., & Parker, D. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2019.0008 · Cited by 28
Sheldon, J. R., Himmel, L. E., Kunkle, D. E., Monteith, A. J., Maloney, K. N., & Skaar, E. P. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010809 · Cited by 29
A model to predict mortality following Pseudomonas aeruginosa bacteremia
Hirsch, E. B., Cottreau, J. M., Chang, K., Caeiro, J., Johnson, M. L., & Tam, V. H. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.09.018 · Cited by 27
“Pseudomonas aeruginosa is a versatile pathogen consistently ranked among the most frequently isolated Gram-negative pathogens implicated in HAIs (Gaynes and Edwards, 2005).”
BackgroundSahly, H., Keisari, Y., & Ofek, I. (2008) · Journal of Innate Immunity · doi:10.1159/000154812 · Cited by 27
“However, the majority of Klebsiella infections affect hospitalized immunocompromised patients with severe underlying diseases [ , , , , , , , ,”
BackgroundYang, Z., Wang, J., Wang, W., Zhang, Y., Han, L., Zhang, Y., Nie, X., & Zhan, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116079 · Cited by 29
Ramirez, M. S., Adams, M. D., Bonomo, R. A., Centrón, D., & Tolmasky, M. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01595-10 · Cited by 27
Grguric, L., Lee, H. H., Gandhi, J. A., Brennan, M. B., DeLeon‐Rodriguez, C. M., Coelho, C., Han, G., & Martinez, L. R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01134 · Cited by 27
Purnapatre, K. P., Rao, M., Pandya, M., Khanna, A., Chaira, T., Bambal, R. B., Upadhyay, D. J., & Masuda, N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01987-17 · Cited by 27
Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model
Lin, S. X. W., Olson, R., Beanan, J. M., MacDonald, U., Russo, T. A., & Balthasar, J. P. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.253617 · Cited by 27
Coolen, J. P. M., den Drijver, E., Kluytmans, J. A. J. W., Verweij, J. J., Lamberts, B. A., Soer, J., Verhulst, C., Wertheim, H. F. L., & Kolwijck, E. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz362 · Cited by 27
Huang, Y., Chang, S., Lauderdale, T.-L. Y., Yang, A. J., & Wang, J. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.009 · Cited by 27
“Pseudomonas aeruginosa is one of the leading pathogens causing nosocomial infections (Gaynes and Edwards, 2005).”
BackgroundMortality risk score for Klebsiella pneumoniae bacteraemia
Zammit, S. C., Azzopardi, N., & Sant, J. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.04.008 · Cited by 27
Biderman, P., Bugaevsky, Y., Ben‐Zvi, H., Bishara, J., & Goldberg, E. (2015) · Clinical Transplantation · doi:10.1111/ctr.12575 · Cited by 27
Wadi, J. A., & Rub, M. A. A. (2007) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2007.456 · Cited by 27
Accelerate Pheno™ Blood Culture Detection System: A Literature Review
Cenci, E., Paggi, R., Socio, G. V. D., Bozza, S., Camilloni, B., Pietrella, D., & Mencacci, A. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0177 · Cited by 29
Sharma, S., Das, A., Banerjee, T., Barman, H., Yadav, G., & Kumar, A. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001345 · Cited by 26
What can Dictyostelium bring to the study of Pseudomonas infections?
de Lima, W. C., Lelong, E., & Cosson, P. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.11.006 · Cited by 32
Valentine, C. D., Anderson, M. O., Papa, F. R., & Haggie, P. M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003576 · Cited by 28
Khorvash, F., Shokri, D., Soltani, R., & Ehsanpoor, M. (2014) · Journal of Research in Pharmacy Practice · doi:10.4103/2279-042x.132703 · Cited by 26
Li, Y., Bai, F., Xia, H., Zhuang, L., Xu, H., Jin, Y., Zhang, X., Bai, Y., & Qiao, M. (2015) · Microbiological Research · doi:10.1016/j.micres.2015.04.001 · Cited by 27
Mostofi, S. (2011) · African Journal of Microbiology Research · doi:10.5897/ajmr11.122 · Cited by 26
Determination of Colistin-Related Nephrotoxicity and Risk Factors in Intensive Care Unit
İnci, A. (2017) · Northern Clinics of Istanbul · doi:10.14744/nci.2017.42243 · Cited by 26
Mączyńska, B., Secewicz, A., Smutnicka, D., Szymczyk‐Ziółkowska, P., Dudek-Wicher, R. K., Junka, A., & Bartoszewicz, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217769 · Cited by 26
El‐Mokhtar, M. A., Daef, E., Hussein, A. A. R. M., Hashem, M. K., & Hassan, H. M. (2021) · Antibiotics · doi:10.3390/antibiotics10030226 · Cited by 29
Mah, G. T., Mabasa, V. H., Chow, I., & Ensom, M. H. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q378 · Cited by 26
Is double coverage of gram-negative organisms necessary?
Johnson, S. J., Ernst, E. J., & Moores, K. G. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090360 · Cited by 27
Rapid detection of antibiotic resistance in Acinetobacter baumannii using quantitative real-time PCR
Martín-Peña, R., Domínguez-Herrera, J., Pachón, J., & McConnell, M. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt057 · Cited by 26
Kroeger, L. A., Hovde, L. B., Mitropoulos, I. F., Schafer, J. A., & Rotschafer, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01433-06 · Cited by 26
Shastri, T., Binsuwaidan, R., Siddiqui, A. J., Badraoui, R., Jahan, S., Alshammari, N., Adnan, M., & Patel, M. B. (2025) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/cjid/2333207 · Cited by 25
“It may be insufcient to use antibiotics despite their necessity, particularly when the infection is aggressively resistant [54–56].”
Iliyasu, G., Dayyab, F. M., Abubakar, S., Inuwa, S., Tambuwal, S. H., Tiamiyu, A. B., Habib, Z. G., Gadanya, M. A., Sheshe, A. A., Mijinyawa, M. S., et al. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00720 · Cited by 27
Kreitmeier, M., Ardern, Z., Abele, M., Ludwig, C., Scherer, S., & Neuhaus, K. (2022) · iScience · doi:10.1016/j.isci.2022.103844 · Cited by 25
The blaSHV-5 gene is encoded in a compound transposon duplicated in tandem in Enterobacter cloacae
Garza–Ramos, U., Dávila, G., González, V., Alpuche-Aranda, C. M., López-Collada, V. R., Alcántar-Curiel, M. D., Newton, O., & Silva-Sánchez, J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02790.x · Cited by 25
“cloacae are currently increasing [2,3] and several SHV-type b-lactamases have been described [4].”
BackgroundVaez, H., Faghri, J., Esfahani, B. N., Moghim, S., Fazeli, H., Sedighi, M., & Safaei, H. G. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.20130v2 · Cited by 25
İraz, M., Düzgün, A. Ö., Çiçek, A. Ç., Bonnin, R. A., Ceylan, A., Saral, A., Nordmann, P., & Sandallı, C. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.12.003 · Cited by 25
Eberle, B. M., Schnüriger, B., Putty, B., Barmparas, G., Kobayashi, L. M., Inaba, K., Belzberg, H., & Δημητριάδης, Δ. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f17af4 · Cited by 25
Thin-section CT findings inPseudomonas aeruginosapulmonary infection
Okada, F., Ono, A., Ando, Y., Nakayama, T., Ishii, R., Sato, H., Kira, A., Tokimatsu, I., Kadota, J.-I., & Mori, H. (2012) · British Journal of Radiology · doi:10.1259/bjr/54468236 · Cited by 25
Importance of Position 170 in the Inhibition of GES-Type β-Lactamases by Clavulanic Acid
Frase, H., Tóth, M., Champion, M. M., Antunes, N. T., & Vakulenko, S. B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-10 · Cited by 26
Antibacterial properties of palladium nanostructures sputtered on polyethylene naphthalate
Polívková, M., Valová, M., Siegel, J., Rimpelová, S., Hubáček, T., Lyutakov, O., & Švorčík, V. (2015) · RSC Advances · doi:10.1039/c5ra09297c · Cited by 25
Fouda, R., Soliman, M. S., ElAnany, M. G., Abadeer, M., & Soliman, G. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6798 · Cited by 28
Webster, T. J., & Machado, M. C. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s108253 · Cited by 25
Modeling Acinetobacter baumannii wound infections: The critical role of iron
Fleming, I. D., Krezalek, M. A., Belogortseva, N., Zaborin, A., DeFazio, J. R., Chandrasekar, L., Actis, L. A., Zaborina, O. Y., & Alverdy, J. C. (2016) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001338 · Cited by 28
Raz‐Pasteur, A., Liron, Y., Amir-Ronen, R., Abdelgani, S., Ohanyan, A., Geffen, Y., & Paul, M. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.12.001 · Cited by 25
Metabolomics of urinary tract infection: a new uroscope in town
Gupta, A. K., Bansal, N., & Houston, B. A. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.27 · Cited by 25
Liao, C., Kung, H., Hsu, G., Lu, P., Liu, Y.-C., Chen, C., Lee, C.-M., Sun, W., Jang, T.-N., Chiang, P.-C., et al. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70027-x · Cited by 25
Vasudevan, A., Memon, B. I., Mukhopadhyay, A., Li, J., & Tambyah, P. A. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0045-8 · Cited by 25
“resistance among gram positive isolates has been stable or decreasing globally, it has been rising among nosocomial gram negative isolates [4].”
Kim, C., Kim, D., LEE, S.-J., Jeong, Y.-J., Kang, M., Lee, J., Choi, J., Kwon, S.-J., Park, J., & PARK, J.-H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1966 · Cited by 25
Clustering of Antimicrobial Resistance Outbreaks Across Bacterial Species in the Intensive Care Unit
Vlek, A. L. M., Cooper, B. S., Kypraios, T., Cox, A., Edgeworth, J. D., & Auguet, O. T. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit192 · Cited by 31
“The occurrence of antimicrobial resistance on the intensive care unit (ICU) is an emerging global concern, particularly with regard to gram-negative bacteria [1–3].”
BackgroundEagye, K. J., Kuti, J. L., Sutherland, C. A., Christensen, H., & Nicolau, D. P. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.11.021 · Cited by 24
Widespread Emergence of Multidrug Resistant Pseudomonas aeruginosa Isolated from CSF Samples
Nagaveni, S., Rajeshwari, H., Oli, A. K., Patil, S. A., & Chandrakanth, R. K. (2011) · Indian Journal of Microbiology · doi:10.1007/s12088-011-0062-0 · Cited by 24
“The most common resistance mechanism is production of beta-lactamases, including penicillinases, cephalosporinases, and carbapenemases [4].”
BackgroundYasir, M., Subahi, A. M., Shukri, H. A., Bibi, F., Sohrab, S. S., Alawi, M., Sindi, A., Jiman-Fatani, A. A., & Azhar, E. I. (2022) · Pharmaceuticals · doi:10.3390/ph15050611 · Cited by 28
Volling, C., Mataseje, L. F., Graña-Miraglia, L., Hu, X., Anceva-Sami, S., Coleman, B. L., Downing, M., Hota, S. S., Jamal, A. J., Johnstone, J., et al. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.03.009 · Cited by 24
Polymorphs of molybdenum trioxide as innovative antimicrobial materials
Shafaei, S., Lackner, M. K., Meier, M., Plank, J., Guggenbichler, J. P., & Zollfrank, C. (2013) · Surface Innovations · doi:10.1680/si.13.00021 · Cited by 24
Antibiogram of Multidrug-Resistant Isolates of Pseudomonas aeruginosa after Biofield Treatment
Branton, A., & Trivedi, D. (2015) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000244 · Cited by 24
Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients
Johnson, J. K., Robinson, G. L., Zhao, L., Harris, A. D., Stine, O. C., & Thom, K. A. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.08.024 · Cited by 24
Golpayegani, A., Nodehi, R. N., Rezaei, F., Alimohammadi, M., & Douraghi, M. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04855-y · Cited by 25
Mayeux, G., Gayet, L., Liguori, L., Odier, M., Martin, D. K., Cortès, S., Schaack, B., & Lenormand, J. (2021) · Life Science Alliance · doi:10.26508/lsa.202000958 · Cited by 24
Rodríguez-Urretavizcaya, B., Pascual, N., Pastells, C., Martín-Gómez, M. T., Vilaplana, L., & Marco, M. ‐. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.786929 · Cited by 25
Pier, G. B., & Ramphal, R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00219-8 · Cited by 46
Geraldo, D. A., Arancibia‐Miranda, N., Villagra, N. A., Mora, G. C., & Arratia‐Pérez, R. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-1286-6 · Cited by 24
Changes in urine composition after trauma facilitate bacterial growth
Aubron, C., Huet, O., Ricôme, S., Borderie, D., Pussard, E., Leblanc, P.-É., Bouvet, O. M. M., Vicaut, É., Denamur, É., & Duranteau, J. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-330 · Cited by 24
“coli, which is the most frequently isolated species in UTIs [7,25].”
BackgroundPark, S. Y., Lee, E. J., Kim, T., Yu, S. N., Park, K., Lee, M. S., Park, S. Y., Jeon, M. H., Kim, T. H., & Choo, E. J. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.10.018 · Cited by 24
Ho, V. P., Jenkins, S. G., Afaneh, C. I., Turbendian, H. K., Nicolau, D. P., & Barie, P. S. (2011) · Surgical Infections · doi:10.1089/sur.2010.072 · Cited by 23
“Gram-negative bacterial resistance to antibiotics increasingly is of concern, as these organisms account for the majority of healthcare-associated infections, including pneumonia and intra-abdominal, urinary tract, and blood stream infections [1].”
BackgroundPaul, J. (2024) · Springer eBooks · doi:10.1007/978-3-031-28567-7_8 · Cited by 23
Metadata
- Authors
- Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-15
- Volume
- 41
- Issue
- 6
- Pages
- 848-854
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2151958462
- Cited by
- 1,404
- References
- 26
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 37 · 2023: 56 · 2022: 73 · 2021: 80 · 2020: 66 · 2019: 78 · 2018: 66 · 2017: 74 · 2016: 86 · 2015: 89 · 2014: 85 · 2013: 95 · 2012: 85
- FWCI
- 38.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial infections, Gram-negative bacilli, intensive care unit, surgical site infection, urinary tract infection, bloodstream infection, Acinetobacter, antimicrobial resistance, epidemiological trends
- MeSH terms
- Cross Infection, Gram-Negative Bacteria, Humans, National Health Programs, Population Surveillance, Surgical Wound Infection, Time Factors, United States, Urinary Tract Infections, Gram-Negative Bacterial Infections, Pneumonia, Bacterial, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.